Biofrontera launches FDA-approved RhodoLED XL lamp for PDT of actinic keratoses

Biofrontera Inc.

RhodoLED XL is FDA-approved for use with Ameluz (aminolevulinic acid) for mild-to-moderate actinic keratoses on face and scalp.
Commercial distribution launched June 10, 2024; first three machines shipped within one week.
Larger illumination area: five panels vs one on prior lamp; includes positioning sensors for optimal energy delivery.
First customer Cleaver Dermatology (MO and GA) installed the XL lamp; response from dermatology organizations is positive.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.